MSC applies advanced data analytics into cultivation, formulation and safety knowledge for the cannabis industry in Canada. It’s our goal to become a global business intelligence leader in database management systems related to laboratory compliance reporting. We are proud to have recognized leaders in pharmaceutical, plant and cannabinoid science working with our company as well as partnerships with organizations such as the University of Guelph, SCIEX, Ample Organics and the Toronto Institute of Pharmaceutical Technology.
Corporate Executive Level
Co-founder and Chief Executive Officer
Chief Operating Officer
Co-Founder and CFO
Howard Goldman, M.B.A.
Brigitte Simons, Ph.D.
VP of Laboratories and Strategic Operations
Mauro Aiello, Ph.D.
VP of Lab Operations and Product Development
David Hyde, M.Sc., CPC.
Alex MacGregor, Ph.D.
Dr. Dean S. Elterman, M.D., F.R.C.S.C.
Chief Medical Officer
Toronto Institute of Pharmaceutical Technology
Pharmaceutical Drug Development and GMP process development.
LC-MS instrumentation and data reporting for high-throughput testing environments.
Canada's #1 cannabis software, this is seed to sale built for compliance.
Molecular Science Corp Investors
Please contact us to receive investor information and updates.Contact Us
Careers with Molecular Science Corp
Molecular Science Corporation (MSC) is the leading cannabis life sciences company focused on advanced product testing, genetics, clinical research and product development. We are committed to using advanced genetic, genomic and physiological techniques to better understand cannabis plant processes. We have established partnerships with the University of Guelph, Ample Organics, and other institutions related to our development of products and services to serve the industry.
MSC is an equal opportunity employer with a drive for growth as a global brand in cannabis scientific advisory services.